Despite advances in medical device technology and large availability of insulin analogues, as well as strenuous attempts to obtain in vitro insulin-producing cells to be transferred into diabetic patients, there is still no fully effective way to yield the fine tuning of secretion and function of the natural hormone or replace the lost β cells in T1D [72]. Here, INS is linked to type 1 diabetes mellitus.